腹膜透析转血液透析后的死亡趋势
该多国注册研究纳入澳大利亚和新西兰、加拿大、欧洲及美国透析登记系统中2000至2014年起始腹膜透析、后转血液透析至少1天的患者,计算转后180天内粗死亡率并分早中晚三期建立Cox模型。结果显示转后30天内粗死亡率最高,随后降至4至6个月最低;高龄、较早起始PD及较长PD龄与死亡风险增加相关,且风险因素随转后时间变化。
要点
- 转血液透析后30天内粗死亡率最高,4至6个月降至最低。
- 高龄、较早起始腹膜透析及较长腹膜透析龄与死亡风险增加相关。
- 转后90天内男性死亡风险低于女性,180天后高于女性。
核心结论
- 该多国研究中,腹膜透析转血液透析后第一个月死亡率最高,且风险因素随转后时间变化。
- 该研究强调模式转换时患者的脆弱性及改善转换过程的需要。
研究设计与样本
- 利用澳大利亚和新西兰透析与移植登记(ANZDATA)、加拿大器官替代登记(CORR)、欧洲肾脏协会(ERA)登记及美国肾脏透析系统(USRDS)数据,纳入2000至2014年起始腹膜透析、后转血液透析至少1天的患者。
- ANZDATA、CORR、ERA登记和USRDS分别纳入6683、5847、21574和80459例患者。
- 计算转后前180天粗死亡率,并分别对转后早期(<90天)、中期(90-180天)和晚期(>180天)建立多变量Cox模型。
主要发现
- 在所有登记中,转血液透析后前30天粗死亡率最高,此后下降,至4至6个月降至最低点。
- 较近年份转换的患者粗死亡率低于较早年份转换者。
- 高龄、较早队列起始腹膜透析及较长腹膜透析龄与死亡风险增加相关,转后前90天关联最强,此后减弱。
- 转后<90天男性死亡风险低于女性,但>180天后男性死亡风险高于女性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Transition to hemodialysis (HD) is a common outcome in peritoneal dialysis (PD), but the associated mortality risk is poorly understood. This study sought to identify rates of and risk factors for mortality after transitioning from PD to HD. METHODS: Patients with incident PD (between 2000 and 2014) who transferred to HD for ≥1 day were identified, using data from Australia and New Zealand Dialysis and Transplantation registry (ANZDATA), Canadian Organ Replacement Register (CORR), Europe Renal Association (ERA) Registry, and the United States Renal Dialysis System (USRDS). Crude mortality rates were calculated for the first 180 days after transfer. Separate multivariable Cox models were built for early (<90 days), medium (90-180 days), and late (>180 days) periods after transfer. RESULTS: Overall, 6683, 5847, 21,574, and 80,459 patients were included from ANZDATA, CORR, ERA Registry, and USRDS, respectively. In all registries, crude mortality rate was highest during the first 30 days after a transfer to HD declining thereafter to nadir at 4 to 6 months. Crude mortality rates were lower for patients transferring in the most recent years (than earlier). Older age, PD initiation in earlier cohorts, and longer PD vintage were associated with increased risk of death, with the strongest associations during the first 90 days after transfer and attenuating thereafter. Mortality risk was lower for men than women <90 days after transfer, but higher after 180 days. CONCLUSION: In this multinational study, mortality was highest in the first month after a transfer from PD to HD and risk factors varied by time period after transfer. This study highlights the vulnerability of patients at the time of modality transfer and the need to improve transitions.
引用
- Nadeau-Fredette AC, Sukul N, Lambie M, et al. Mortality Trends After Transfer From Peritoneal Dialysis to Hemodialysis. Kidney Int Rep. 2022. PMID: 35570995. doi:10.1016/j.ekir.2022.02.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。